Full list · page 4 of 11
All companies: Research and experimental development on natural sciences and engineering
The 1,069 companies whose main activity is “Research and experimental development on natural sciences and engineering” (NACE 7210) and that have filed annual accounts, by company number, 100 per page.
| Company | Company number | Total assets | Year |
|---|---|---|---|
| Agroptimize 6700 Arlon | 0650.675.505 | €2.07m | 2025 |
| Raap België 9810 Nazareth-De Pinte | 0651.739.832 | 997,017 € | 2025 |
| OCTIMET Oncology 2440 Geel | 0651.853.757 | 252,753 € | 2025 |
| sil'innov 6220 Fleurus | 0651.902.356 | 484,486 € | 2025 |
| Duurzaam Repareren Belgium 2000 Antwerp | 0652.694.885 | 273,963 € | 2025 |
| Tinne Geens 2960 Brecht | 0652.789.412 | 405,488 € | 2025 |
| SciMedBE 3000 Leuven | 0652.860.676 | 777,944 € | 2025 |
| Point IMC 3078 Kortenberg | 0652.953.817 | 293,583 € | 2026 |
| FOx Biosystems 3590 Diepenbeek | 0653.744.366 | €2.72m | 2023 |
| Energy & Engineering 1785 Merchtem | 0654.844.327 | 5,558 € | 2025 |
| Alphabiotoxine Laboratory 7911 Frasnes-lez-Anvaing | 0654.859.074 | 110,739 € | 2025 |
| Brein Instituut 2610 Antwerp | 0655.917.562 | 974,856 € | 2025 |
| Cannovex 3590 Diepenbeek | 0656.491.644 | €1.09m | 2025 |
| Casc8 3140 Keerbergen | 0656.577.261 | 822,069 € | 2025 |
| PDC line Pharma 4000 Liège | 0657.842.221 | €3.76m | 2024 |
| Biocidal Alternative Solutions 4480 Engis | 0658.960.293 | €1.21m | 2025 |
| InnoSer België 3590 Diepenbeek | 0659.654.141 | €2.12m | 2025 |
| CellCarta Biosciences 6041 Charleroi | 0661.567.021 | €22.4m | 2023 |
| Oncoradiomics 4000 Liège | 0662.719.440 | €4.31m | 2025 |
| Resource Matters 1210 Saint-Josse-ten-Noode | 0662.969.264 | 956,639 € | 2025 |
| Phytex 1490 Court-Saint-Étienne | 0663.738.633 | 42,587 € | 2025 |
| Brussels Medical Device Center 1070 Anderlecht | 0663.935.801 | 218,935 € | 2025 |
| The Akkermansia Company 1435 Mont-Saint-Guibert | 0664.529.083 | €16.9m | 2025 |
| IME 8970 Poperinge | 0664.856.410 | 207,713 € | 2025 |
| Aphea.Bio 9052 Ghent | 0666.961.607 | €16.2m | 2025 |
| Arabian Horse Results 3300 Tienen | 0667.735.429 | 340,337 € | 2025 |
| Sustaineer 9000 Ghent | 0667.929.330 | 299,595 € | 2025 |
| Equaly 1348 Ottignies-Louvain-la-Neuve | 0667.996.636 | €1.87m | 2023 |
| S-Biomedic 9052 Ghent | 0668.407.105 | €5.94m | 2025 |
| Sticon 8700 Tielt | 0668.500.244 | 637,100 € | 2025 |
| care2trans 9820 Merelbeke-Melle | 0669.887.344 | 817,653 € | 2025 |
| Sympli Good Food 9000 Ghent | 0671.744.794 | 258,407 € | 2025 |
| Convert Pharmaceuticals 4000 Liège | 0671.828.631 | 941,204 € | 2025 |
| Novobiom 4000 Liège | 0671.829.819 | €3.92m | 2025 |
| TYROScreen 4653 Herve | 0672.589.090 | 48,550 € | 2025 |
| Roger 1380 Lasne | 0672.875.142 | 151,258 € | 2025 |
| Bridging for Sustainability 4560 Clavier | 0673.811.389 | 44,057 € | 2025 |
| RIPEnergy 4020 Liège | 0674.399.626 | 884,389 € | 2025 |
| Cornet & Renard 3212 Lubbeek | 0674.465.348 | 258,967 € | 2025 |
| Art-Company 9940 Evergem | 0674.575.612 | 319,077 € | 2025 |
| Creatleen Consultancy 9160 Lokeren | 0674.954.704 | 3,281 € | 2025 |
| Care&D 6880 Bertrix | 0676.669.426 | 112,187 € | 2025 |
| Cryoport Belgium 4530 Villers-le-Bouillet | 0676.713.669 | €16.2m | 2025 |
| Dr. Marc Lambelin 2590 Berlaar | 0676.878.173 | 490,068 € | 2025 |
| Delft Environment Technology 1082 Berchem-Sainte-Agathe | 0677.707.029 | 8,705 € | 2025 |
| Vascular Research Center Bonheiden 2270 Herenthout | 0677.749.094 | 159,871 € | 2025 |
| Consulting Claudine Demeyere 1700 Dilbeek | 0678.456.701 | 66,460 € | 2025 |
| BioGenCell Europe SA 1410 Waterloo | 0678.674.356 | 386,698 € | 2025 |
| ProteoFormiX 2290 Vorselaar | 0678.992.278 | 182,817 € | 2025 |
| European Research Infrastructure on Highly Pathogenic Agents 1050 Ixelles | 0679.481.238 | €7.60m | 2025 |
| Fertiga 9340 Lede | 0680.559.621 | €2.06m | 2025 |
| Dr. Rosseels Alexander 3920 Lommel | 0681.511.508 | 127,562 € | 2025 |
| Rejuvenate Biomed 3590 Diepenbeek | 0681.964.735 | €3.45m | 2025 |
| ReWind Therapeutics 3001 Leuven | 0682.626.216 | €2.09m | 2025 |
| Asterion Research & Development 9000 Ghent | 0682.704.608 | €2.31m | 2025 |
| Biotec International Corporate 1348 Ottignies-Louvain-la-Neuve | 0683.671.935 | 301,739 € | 2025 |
| Focus Clinical Consultancy 3740 Bilzen-Hoeselt | 0683.792.293 | 571,822 € | 2025 |
| NemaTerra 2280 Grobbendonk | 0683.893.649 | €2.02m | 2025 |
| Qualiblood 4000 Liège | 0684.698.353 | €2.63m | 2024 |
| Phinaïs 1150 Woluwe-Saint-Pierre | 0684.977.079 | €70.0m | 2025 |
| Europharmedtech 1083 Ganshoren | 0685.431.593 | 54,960 € | 2025 |
| Mitral Technologies 4000 Liège | 0685.758.128 | €1.48m | 2019 |
| Syndesi Therapeutics 1300 Wavre | 0686.599.355 | 607,532 € | 2025 |
| MCLC 8210 Zedelgem | 0687.576.877 | 351,344 € | 2025 |
| Trenker Nutrition 1402 Nivelles | 0688.640.216 | 72,988 € | 2025 |
| Mixed Matrix Material Innovations 2160 Wommelgem | 0689.655.152 | 107,675 € | 2025 |
| Managerial Genetics Consulting 3680 Maaseik | 0689.673.859 | 436,140 € | 2025 |
| Hello Pharma 4020 Liège | 0689.779.668 | 302,014 € | 2025 |
| AB Register vzw 1000 Brussels | 0689.903.689 | 442,721 € | 2025 |
| Indar 2340 Beerse | 0690.558.737 | €1.20m | 2025 |
| Sillar Clinical 9831 Sint-Martens-Latem | 0692.746.878 | 811,427 € | 2025 |
| Alixar 3511 Hasselt | 0693.937.307 | €18.5m | 2025 |
| Transversality 1140 Evere | 0694.581.861 | 293,152 € | 2025 |
| Pagotini 5100 Namur | 0697.822.057 | 63,313 € | 2025 |
| Fermedics 9050 Ghent | 0698.608.846 | €1.01m | 2025 |
| IndusFilter 9050 Ghent | 0698.642.894 | 443,685 € | 2025 |
| DGBO 2360 Oud-Turnhout | 0700.269.328 | 880,605 € | 2025 |
| NB Please 6700 Arlon | 0700.420.271 | 150,024 € | 2025 |
| Nuphar Tech 8670 Koksijde | 0700.488.270 | 20,308 € | 2025 |
| Dendrogenix 4000 Liège | 0700.613.677 | €5.28m | 2025 |
| FLGM Consulting 4210 Burdinne | 0701.909.618 | 912,045 € | 2025 |
| Lisa Florin 9880 Aalter | 0702.956.822 | 757,585 € | 2025 |
| AgenTus Therapeutics 1410 Waterloo | 0702.962.265 | €4.55m | 2018 |
| Aligos Belgium 3001 Leuven | 0702.969.886 | €1.82m | 2025 |
| Inari Agriculture, NV 9052 Ghent | 0705.873.156 | €12.1m | 2025 |
| AJN Management 1080 Molenbeek-Saint-Jean | 0707.758.619 | 4,176 € | 2025 |
| OSIVAX Belgique 4031 Liège | 0707.772.871 | €17.0m | 2025 |
| Cubatik 4367 Crisnée | 0707.842.256 | 151,712 € | 2025 |
| Nirts 1930 Zaventem | 0711.804.410 | 3,831 € | 2022 |
| Dokter Katrien Scheers huisarts 3140 Keerbergen | 0712.585.952 | 88,527 € | 2025 |
| FOXY 6698 Vielsalm | 0712.621.881 | 153,611 € | 2025 |
| Spectralys Biotech 6041 Charleroi | 0712.775.992 | 444,695 € | 2025 |
| Bulnes Consulting 3061 Bertem | 0713.473.305 | 147,364 € | 2025 |
| ProtonW.be 6041 Charleroi | 0713.654.140 | €1.27m | 2025 |
| BioLizard 9000 Ghent | 0713.914.951 | €5.26m | 2025 |
| Bueds Clinical Services 2580 Putte | 0713.983.643 | 315,569 € | 2025 |
| Minoryx Therapeutics BE 6041 Charleroi | 0713.984.534 | €3.87m | 2025 |
| myNeo 9000 Ghent | 0715.710.837 | €2.21m | 2025 |
| Avigene 1050 Ixelles | 0715.739.739 | €1.67m | 2025 |
| TherioPharm 1300 Wavre | 0715.780.024 | 9,763 € | 2025 |
← Back to Research and experimental development on natural sciences and engineering